Madrigal Pharma News, Madrigal Pharma Quote, MDGL Quote

Madrigal Pharma (NQ:MDGL) Delayed: 238.29 --0 (-0%)

Prev. Close

$238.29

Open

$238.29

52 Wk High

$18.24

52 Wk Low

$6.60

Day High

$238.29

Day Low

$238.29

P/E

N/A

EPS

$0.00

Volume

Friends, Peers and Foes (?): TERN, AKRO, VKTX HTGC (more...)

Feb 28, 2023 07:24 AM Madrigal Pharmaceuticals (MDGL) PT Raised to $336 at Canaccord Genuity
Feb 27, 2023 07:35 AM Madrigal Pharmaceuticals (MDGL) PT Raised to $300 at Oppenheimer
Feb 23, 2023 08:00 AM Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quarter and Full Year Financial Results
Feb 8, 2023 08:00 AM Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
Jan 6, 2023 08:01 AM Madrigal Pharma (MDGL) Announces Additional Positive Results from Phase 3 MAESTRO-NASH Trial
Jan 6, 2023 08:00 AM Madrigal Announces Additional Positive Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of Resmetirom for the Treatment of NASH with Liver Fibrosis
Jan 6, 2023 07:59 AM Madrigal Pharmaceuticals (MDGL) PT Raised to $296 at Canaccord Genuity
Jan 5, 2023 02:18 AM Madrigal Pharmaceuticals (MDGL) PT Raised to $390 at JMP Securities
Dec 21, 2022 04:17 PM Madrigal Pharma (MDGL) Raises Over $300M to Advance Resmetirom Program
Dec 21, 2022 04:15 PM Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program

Entities mentioned with MDGL